WARREN, N.J. (AP) _ Aquestive Therapeutics Inc. (AQST) on Tuesday reported a loss of $20.5 million in its second quarter.
The Warren, New Jersey-based company said it had a loss of 82 cents per share.
The specialty pharmaceutical company posted revenue of $11.1 million in the period.
Aquestive Therapeutics expects full-year revenue in the range of $38 million to $45 million.
In the final minutes of trading on Tuesday, the company's shares hit $3.15. A year ago, they were trading at $15.